CNVIF — Conavi Medical Share Price
0.000.00%
Last trade - 00:00- $15.98m
- $26.50m
- CA$23.79m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.56 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -114.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | 26.82 | 25.19 | n/a | 23.79 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
Directors
- Paul Cataford CHM (57)
- Stephen Lemieux CFO
- Perry Genova SVP
- Chien Huang VFN
- Chris Seibert VPR
- Kristen Galfetti VPR
- Tammy Carrea VPR
- Anthony Giovinazzo LED
- Heather Knight IND
- Cary Vance IND (51)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2024
- Incorporated
- July 28th, 2008
- Public Since
- April 28th, 2008
- No. of Employees
- 4
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 44,250,086
- Address
- 76 Berkeley Street, TORONTO, M5A 2W7
- Web
- https://titanmedicalinc.com/
- Phone
- +1 4165487522
- Auditors
- MNP LLP
Upcoming Events for CNVIF
Similar to CNVIF
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
What is the Conavi Medical share price?
As of Today at 20:02 UTC, shares in Conavi Medical are trading at $0.36. This share price information is delayed by 15 minutes.
How has the Conavi Medical share price performed this year?
Shares in Conavi Medical last closed at $0.36 and the price had moved by +809.67% over the past 365 days. In terms of relative price strength the Conavi Medical share price has outperformed the S&P500 Index by +759.59% over the past year.
What are the analyst and broker recommendations for Conavi Medical?
The overall consensus recommendation for Conavi Medical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Conavi Medical dividend yield?
Conavi Medical does not currently pay a dividend.
Does Conavi Medical pay a dividend?
Conavi Medical does not currently pay a dividend.
When does Conavi Medical next pay dividends?
Conavi Medical does not currently pay a dividend.
How do I buy Conavi Medical shares?
To buy shares in Conavi Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Conavi Medical?
As of the previous close price of $0.36, shares in Conavi Medical had a market capitalisation of $15.98m.
Where are Conavi Medical shares listed?
Here are the trading details for Conavi Medical:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CNVIF
What kind of share is Conavi Medical?
Based on an overall assessment of its quality, value and momentum Conavi Medical is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Conavi Medical share price forecast for 2025?
The analyst consensus target price for shares in Conavi Medical is $1.96. That is 449.22% above the last closing price of $0.36.
Analysts covering Conavi Medical currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Conavi Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Conavi Medical. Over the past six months, its share price has outperformed the S&P500 Index by +1080.98%.
As of the last closing price of $0.36, shares in Conavi Medical were trading +23.29% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Conavi Medical PE Ratio?
The Conavi Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.36.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Conavi Medical?
Conavi Medical's management team is headed by:
- Paul Cataford - CHM
- Stephen Lemieux - CFO
- Perry Genova - SVP
- Chien Huang - VFN
- Chris Seibert - VPR
- Kristen Galfetti - VPR
- Tammy Carrea - VPR
- Anthony Giovinazzo - LED
- Heather Knight - IND
- Cary Vance - IND